The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Safety results of Q-1802, a Claudin18.2/PD-L1 bsABs, in patients with relapsed or refractory solid tumors in a phase 1 study.
 
Jifang Gong
No Relationships to Disclose
 
Lin Shen
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squib; Daiichi Sankyo; Harbour BioMed; Merck; Mingji biopharmaceutical; MSD; Roche
Speakers' Bureau - Hutchison Whampoa; MSD
Research Funding - Baiji Shenzhou (Beijing) Biotechnology (Inst); Beijing Xiantong Biomedical Technology (Inst); Nanjing Yaojieankang Biotechnology (Inst); QiLu Pharmaceutical (Inst); Zaiding Pharmaceutical (Inst)
 
Jie Hou
No Relationships to Disclose
 
Xiaohua Chen
No Relationships to Disclose
 
Qin Yu
No Relationships to Disclose
 
Ying Zheng
No Relationships to Disclose
 
Yakun Wang
No Relationships to Disclose
 
Jian Zhang
No Relationships to Disclose
 
Xiangdong Qu
No Relationships to Disclose
 
Qiying Lu
Employment - Qurebio Ltd.
Leadership - Qurebio Ltd.
Stock and Other Ownership Interests - Qurebio Ltd.
 
Yejie Du
No Relationships to Disclose
 
Qin Pan
No Relationships to Disclose
 
Wencheng Xu
Employment - Qurebio Ltd.